BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 11483205)

  • 1. The inter-heavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bonds.
    Schuurman J; Perdok GJ; Gorter AD; Aalberse RC
    Mol Immunol; 2001 Jan; 38(1):1-8. PubMed ID: 11483205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrachain disulfide bond in the core hinge region of human IgG4.
    Bloom JW; Madanat MS; Marriott D; Wong T; Chan SY
    Protein Sci; 1997 Feb; 6(2):407-15. PubMed ID: 9041643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic insights into inter-chain disulfide bond reduction of IgG1 and IgG4 antibodies.
    Song Y; Cai H; Tan Z; Mussa N; Li ZJ
    Appl Microbiol Biotechnol; 2022 Feb; 106(3):1057-1066. PubMed ID: 35072737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fc-Fc interactions of human IgG4 require dissociation of heavy chains and are formed predominantly by the intra-chain hinge isomer.
    Rispens T; Meesters J; den Bleker TH; Ooijevaar-De Heer P; Schuurman J; Parren PW; Labrijn A; Aalberse RC
    Mol Immunol; 2013 Jan; 53(1-2):35-42. PubMed ID: 22784992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human myeloma immunoglobulins of the fourth subclass (IgG4 MAM) contain a fraction with different properties of CH2 domains.
    Tischenko VM
    Biochemistry (Mosc); 2015 Jan; 80(1):21-30. PubMed ID: 25754036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG4 breaking the rules.
    Aalberse RC; Schuurman J
    Immunology; 2002 Jan; 105(1):9-19. PubMed ID: 11849310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of inter-heavy chain interactions in human immunoglobulin G (IgG) subclasses studied by kinetic Fab arm exchange.
    Rispens T; Davies AM; Ooijevaar-de Heer P; Absalah S; Bende O; Sutton BJ; Vidarsson G; Aalberse RC
    J Biol Chem; 2014 Feb; 289(9):6098-109. PubMed ID: 24425871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering an improved IgG4 molecule with reduced disulfide bond heterogeneity and increased Fab domain thermal stability.
    Peters SJ; Smales CM; Henry AJ; Stephens PE; West S; Humphreys DP
    J Biol Chem; 2012 Jul; 287(29):24525-33. PubMed ID: 22610095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative stabilities of IgG1 and IgG4 Fab domains: influence of the light-heavy interchain disulfide bond architecture.
    Heads JT; Adams R; D'Hooghe LE; Page MJ; Humphreys DP; Popplewell AG; Lawson AD; Henry AJ
    Protein Sci; 2012 Sep; 21(9):1315-22. PubMed ID: 22761163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of inter-heavy and light chain disulfide bonds in the effector functions of human immunoglobulin IgG1.
    Dorai H; Wesolowski JS; Gillies SD
    Mol Immunol; 1992 Dec; 29(12):1487-91. PubMed ID: 1454066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranking the susceptibility of disulfide bonds in human IgG1 antibodies by reduction, differential alkylation, and LC-MS analysis.
    Liu H; Chumsae C; Gaza-Bulseco G; Hurkmans K; Radziejewski CH
    Anal Chem; 2010 Jun; 82(12):5219-26. PubMed ID: 20491447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L
    Xu CA; Feng AZ; Ramineni CK; Wallace MR; Culyba EK; Guay KP; Mehta K; Mabry R; Farrand S; Xu J; Feng J
    MAbs; 2019 Oct; 11(7):1289-1299. PubMed ID: 31199179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The crystallizable human myeloma protein Dob has a hinge-region deletion.
    Steiner LA; Lopes AD
    Biochemistry; 1979 Sep; 18(19):4054-67. PubMed ID: 114208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chip-based gel electrophoresis method for the quantification of half-antibody species in IgG4 and their by- and degradation products.
    Forrer K; Hammer S; Helk B
    Anal Biochem; 2004 Nov; 334(1):81-8. PubMed ID: 15464955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human IgG is substrate for the thioredoxin system: differential cleavage pattern of interchain disulfide bridges in IgG subclasses.
    Magnusson CG; Björnstedt M; Holmgren A
    Mol Immunol; 1997 Jul; 34(10):709-17. PubMed ID: 9430198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The apparent monovalency of human IgG4 is due to bispecificity.
    Aalberse RC; Schuurman J; van Ree R
    Int Arch Allergy Immunol; 1999; 118(2-4):187-9. PubMed ID: 10224373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific antibody-drug conjugate heterogeneity characterization and heterogeneity root cause analysis.
    Cao M; De Mel N; Jiao Y; Howard J; Parthemore C; Korman S; Thompson C; Wendeler M; Liu D
    MAbs; 2019; 11(6):1064-1076. PubMed ID: 31198090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of sodium dodecyl sulfate-polyacrylamide gel electrophoresis sample preparation artifacts for analysis of IgG4 half-antibody.
    Taylor FR; Prentice HL; Garber EA; Fajardo HA; Vasilyeva E; Blake Pepinsky R
    Anal Biochem; 2006 Jun; 353(2):204-8. PubMed ID: 16564018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of inter-heavy chain disulfide bond formation of liganded and unliganded human immunoglobulin G by radioimmunoassay.
    Azuma T; Takeda J; Motoyama N; Okada H
    Mol Immunol; 1992 Jan; 29(1):37-44. PubMed ID: 1731190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human IgG3 can adopt the disulfide bond pattern characteristic for IgG1 without resembling it in complement mediated cell lysis.
    Brekke OH; Bremnes B; Sandin R; Aase A; Michaelsen TE; Sandlie I
    Mol Immunol; 1993 Nov; 30(16):1419-25. PubMed ID: 8232327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.